MANSFIELD, Mass.--(BUSINESS WIRE)--May. 8, 2013--
Covidien
(NYSE: COV), a leading global provider of healthcare products, will
present at the Bank of America Merrill Lynch 2013 Health Care Conference
in Las Vegas, NV, on Wednesday, May 15, 2013.
Bryan Hanson, Group President, Surgical Solutions, will represent the
Company in a session scheduled at 1:40 p.m. ET.
Mark Trudeau, President, Pharmaceuticals, will discuss Mallinckrodt, the
pharmaceuticals business of Covidien, in a session scheduled to begin at
2:20 p.m. ET.
A live audio webcast of the presentations can be accessed at Covidien’s
Investor Relations website: http://investor.covidien.com.
ABOUT COVIDIEN
Covidien is a leading global healthcare
products company that creates innovative medical solutions for better
patient outcomes and delivers value through clinical leadership and
excellence. Covidien manufactures, distributes and services a diverse
range of industry-leading product lines in three segments: Medical
Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of
$11.9 billion, Covidien has 43,000 employees worldwide in 70 countries,
and its products are sold in over 140 countries. Please visit www.covidien.com
to learn more about our business.
Source: Covidien
Covidien
Jacqueline Strayer, 508-261-8305
Senior Vice President
Corporate
Communications
jacqueline.strayer@covidien.com
or
Coleman
Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Bruce
Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Todd
Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com
| 
View printer-friendly version
